Molecular Templates, Inc.: Nasdaq/NYSE listing notice — Molecular Templates receives Nasdaq notice for failure to meet $2.5M equity requirement

Molecular Templates, Inc.

Received additional Nasdaq deficiency notice on Apr 4, 2023 for failing $2.5M minimum stockholders' equity requirement (Listing Rule 5550(b)(2)).
Company will present compliance plan at upcoming Nasdaq Hearings Panel; no assurance of continued listing.
Shares trade under MTEM on Nasdaq Capital Market; delisting risk heightened.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Molecular Templates, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(2)

Exact text from the filing

April 4, 2023, Molecular Templates, Inc. (the “Company”) received an additional notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company no longer satisfied the $2.5 million minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “Equity Requirement”), which could serve as an additional basis for the delisting of the Company’s securities from Nasdaq. The Company plans to present its plan to evidence compliance with the Equity Requirement along with i

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-095265

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.